Posttranslational Modifications and the Immunogenicity of Biotherapeutics
Whilst the amino acid sequence of a protein is determined by its gene sequence, the final structure and function are determined by posttranslational modifications (PTMs), including quality control (QC) in the endoplasmic reticulum (ER) and during passage through the Golgi apparatus. These processes...
Saved in:
Main Author: | Roy Jefferis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2016/5358272 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of PCNA Posttranslational Modifications in Translesion Synthesis
by: Montaser Shaheen, et al.
Published: (2010-01-01) -
Wnt/GSK‐3β mediates posttranslational modifications of FLYWCH1 to regulate intestinal epithelial function and tumorigenesis in the colon
by: Sheema Almozyan, et al.
Published: (2025-01-01) -
Intricacies for Posttranslational Tumor-Targeted Cytokine Gene Therapy
by: Jeffry Cutrera, et al.
Published: (2013-01-01) -
Development of an mPBPK machine learning framework for early target pharmacology assessment of biotherapeutics
by: Krutika Patidar, et al.
Published: (2025-02-01) -
Anti-SARS-CoV-2 Biotherapeutics and Chemotherapeutics: An Insight into Product Specifications and Marketing Dynamics
by: Vijay Kotra, et al.
Published: (2022-12-01)